396 Risk Factors Associated to Mortality in Mmexican Children with Stevens-Johnson Sndrome/Toxic Epidermal Necrolysis
Autor: | Luis Octavio Hernandez-Mondragon, Armando Partida-Gaytán, Blanca del Rio, Eduardo Almeida-Gutierrez, Miguel Angel Rosas-Vargas |
---|---|
Rok vydání: | 2012 |
Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty integumentary system business.industry digestive oral and skin physiology Immunology Stevens johnson Poster Session medicine.disease Abstracts of the XXII World Allergy Congress Data science Dermatology Toxic epidermal necrolysis stomatognathic diseases Immunology and Allergy Medicine business |
Zdroj: | The World Allergy Organization Journal |
ISSN: | 1939-4551 |
DOI: | 10.1097/01.wox.0000412159.16865.f9 |
Popis: | Background and Objective Identify risk factors associated to mortality in Mexican children with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Methods Cross-sectional analytical study. We reviewed the medical records of patients with hospitalization and primary diagnosis of Stevens-Johnson syndrome (SJS) or Toxic Epidermal Necrolysis (TEN) from January 1995 to May 2011. Our study variables have been previously described. We describe median (interquartilar range: IR) and percentage. Exact Fisher test, Mann Withney U and binary logistic regression were used. Results We obtained 51 medical records: 24 male (47.1%), 27 female (53%). Median age was 5 years (IR 2–8). Thirty eight (76%) corresponded to SJS, four (7.8%) to SJS-TEN overposition and nine (15.7%) to TEN. Mortality was seen in 9 patients (17.6%, 6 male [66.8%] and 3 female [33.3%], P > 0.05). Twenty two cases (43%) were attributed to anticonvulsive drugs, twenty (39%) to antibiotics, two (4%) to non-steroid anti-inflammatory drugs, two (4%) to infection, one (2%) to chemotherapeutic drugs, and in two (4%) no trigger factor was identified. Risk factors associated to mortality were: denudation of >30% Body Surface Area (BSA) (7.1% vs 55.6% P < 0.001), concomitant malignancy (0% vs 22.2% P < 0.028), moderate leucopenia (20,000 cells/mL) (7.3% vs 22.2%, P < 0.001), hypokalemia (5.0 mEq/L) (5.6% vs 22.2%, P < 0.011). Total bilirrubin concentration >3.6 mg/dL has tendency to associate with mortality, P = 0.08. Six patients (11.7%) were treated with steroids, fifteen (29.4%) with IV human immunoglobulin and one (1.9%) with both drugs, no statistical difference was observed, though the steroid-treated group showed a tendency towards mortality increase. Some variables were not able to analyze due incomplete medical records. Conclusions Risk factors associated to mortality in patients with SSJ/TEN identified in this study are: skin denudation >30% BSA, concomitant malignancy, leucopenia, leukocytosis, hypokalemia and hyperkalemia. Total bilirrubin concentration >3.6 mg/dL has tendency to associate with mortality, although not statistically significant. |
Databáze: | OpenAIRE |
Externí odkaz: |